Many stocks have been testing new highs in 2020, and one of the most notable is ADC Therapeutics SA (ADCT). Currently, ADCT is trading at $36.65.
To add more color to this target, the company’s high over the last year is $37.98 and the low is $28.50. Over the last 52 weeks, ADCT is down -3.50% while the S&P 500 is down -0.75%. The catalyst for this interesting swing was the company’s recent earnings report.
A Notable Earnings Report
In the last quarter, ADCT reported a profit of $112.9 million. ADC Therapeutics SA also saw revenues increase to $312.6 million. In addition, ADCT has free cash flow of $107.2 million as of 09-2010 The company’s EBITDA came in at $31.3 million which compares well with its peers.
Find out when ADCT reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.
Of course, we must look beyond the financials and question how well those numbers represent the sustainable earnings power of the business. Investors need to know how sustainable this current run. ADCT has outstanding shares of 68.97M.
ADCT has seen increased volume after this news and investors are putting their support behind the value proposition. Furthermore, 10-day volume stands at 0.23 million and more growth is possible in the weeks ahead. Traders will also note the company’s earnings per share came in at -1.52. ADC Therapeutics SA ADCT also noted assets of $1.47 billion at the end of the last quarter. Investors should also keep an eye on sector updates as ADCT has historically followed its peers on positive news.
All told, ADC Therapeutics SA ADCT has strung together solid data and demonstrated underlying fundamentals. At its current valuation, ADCT represents an interesting risk/reward case. Traders should stay tuned to see if this recent report will push the stock to test recent resistance levels.
ADC Therapeutics SA ADCT is now commanding a market cap of 2.53B and a float of 34.62M. ADCT is increasing its credibility in this sector and that could lead to more upside down the line. Sign-up for continuing coverage on shares of ADCT stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!
Disclosure: we hold no position in ADCT, either long or short, and we have not been compensated for this article.